said, “We are thrilled to have receivedU.S. Food and Drug Administration(“FDA”) approval for Emrosi™, a potential best-in-class treatment for inflammatory lesions of rosacea in adults, which is a tremendous milestone for Fortress and our partner company, Journey Medical Corpor...
Ospedale San Raffaele is a first-class institute which treats many diseases and stands out for the deep interaction between clinical and scientific area. This makes the transfer of scientific results from the laboratories to the patient’s bed easier. Its mission is to improve knowledge of...
Brandywine is the city’s largest owner of trophy office buildings and has several major development projects in the works. The company is planning to eventually develop 3 million square feet of life sciences space. For now, 800,000 square feet of life sciences space is under development, inclu...
This new class of therapies has shown the potential to bring transformative benefit to patients. With dozens of AAV treatments in clinical studies, all eyes are on the field to gauge its disruptive impact. The panel assesses the largest challenges of the first two products, the lessons learned ...
Her company is working to develop a new class of RNA medicines directed at transfer RNAs, also known as tRNA. The gist of the idea is to make these tRNA therapies, delivered with a lipid nanoparticle, that can carry instructions to overwrite a premature termination codon. The premature termina...
Notes to Condensed Consolidated Financial Statements (unaudited) 1. Organization Founded in 2016, Krystal Biotech, Inc. (the “Company,” or “we” or other similar pronouns) is a fully integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing and commercia...
Jonathan has a popular TED talk about “the secret to self-control” that you can find in the show notes on TimmermanReport.com. He has found broad audiences for this work, at one point capturing the imagination ofcomedian Trevor Noah. And FYI, I’ve known Jonathan a while, as he happe...
January 13, 2025 · 2 min read · Tristan Manalac IPO Metsera Moves Fast in Crowded Obesity Market With IPO Plans January 13, 2025 · 2 min read · Tristan Manalac Mergers & acquisitions GSK Targets Rare Cancer With $1B+ Acquisition of IDRx ...
December 19, 2024 · 2 min read · Tristan Manalac GLP-1 GLP-1s Potentially ‘Transformative’ but Could Lead to ‘Distorted’ Obesity Care: WHO December 19, 2024 · 2 min read · Tristan Manalac Layoff Tracker Ring Therapeutics Lets Go of Nearly Half Its Staff ...
2nd in class only takes 4 years while 3rd in class drugs take only 1.5 years Health-in-a-fish: using a CRE system to go from disease to normal The theory is making a CRE or CURE avatar; taking a diseased zebrafish and reverse engineering the disease genome ...